-
December 24, 2018 Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to treat Hematological Cancers
-
December 20, 2018 Lupin’s Pithampur Unit-3 (Indore) receives EIR from US FDA
-
December 20, 2018 Lupin receives tentative US FDA approval for Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mgn
-
December 20, 2018 Lupin receives tentative US FDA approval for Tadalafil Tablets USP, 20 mg
-
December 20, 2018 Lupin receives US FDA approval for Clobazam Tablets, 10 mg and 20 mg
-
December 6, 2018 Lupin launches generic Tetrabenazine Tablets
-
December 6, 2018 Lupin launches India’s first chatbot for patients
-
December 6, 2018 Lupin receives FDA approval for KCl for Oral Solution 20 mEq
-
December 6, 2018 Lupin receives FDA approval for Clomipramine HCl Capsules
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications